Medication info
Clothin Tablets (Clarithromycin)

Clothin Tablets (Clarithromycin)

Prescription medicationTabletOral
Ingredient · strength
Clarithromycin›250mg / 1 tablet
Manufacturer / importer
Austin Pharmaceutical Co., Ltd.
Appearance
Yellow oblong film-coated tablet
Packaging
100 tablets/bottle, 30 tablets/bottle
Approval status
Active

MFDS item code 200402091 · Notified 2004.10.13 · Insurance code 654302870

Summary

Main use
Treatment of respiratory and skin infections, mycobacterial infections, and Helicobacter pylori eradication
Who takes it
Adults · Children
Adult dose
Adults: The usual dose of clarithromycin is 250 mg (potency) per dose 2 times daily; for severe infections, administer 500 mg (potency) per dose 2 times daily. The usual treatment duration is 7–14 days. In patients with renal failure and creatinine clearance of 30 mL/min or less, the dose should be reduced by half: 250 mg (potency) once daily, or, for severe infections, 250 mg (potency) per dose 2 times daily. Do not administer to these patients for more than 14 days. Mycobacterial infections: Administer 500 mg (potency) per dose 2 times daily. In this case, it should be administered concomitantly with other antimycobacterial agents, such as ethambutol, clofazimine, and rifampin. Eradication of Helicobacter pylori in patients with duodenal ulcers: Administer clarithromycin 500 mg (potency) 3 times daily for 14 days in combination with omeprazole 40 mg once daily, followed by omeprazole 40 mg once daily for 14 consecutive days. That is, administer clarithromycin 500 mg (potency) per dose 3 times daily for 14 days (days 1–14), and omeprazole 40 mg once daily for 28 days (days 1–28). Children 12 years of age and older: same as adults.
Child dose
For children under 12 years of age, use clarithromycin dry syrup.

Ingredients

Manufacturer
Austin Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of respiratory and skin infections, mycobacterial infections, and Helicobacter pylori eradication

  • Bronchitis
  • pneumonia
  • pharyngitis
  • sinusitis
  • skin and soft tissue infections
  • mycobacterial infections
  • duodenal ulcers
View approved original text

This medication is used to treat infections caused by various bacteria. It is effective not only for lower respiratory tract infections such as bronchitis and pneumonia, but also for upper respiratory tract infections such as pharyngitis and sinusitis. It is also utilized to treat infections occurring on the skin and soft tissues. It is used for infections caused by Mycobacterium avium and Mycobacterium intracellulare, and helps to eradicate Helicobacter pylori in patients with duodenal ulcers. In summary, this drug is used to improve various bacterial infections.

How to take

Adult dose

Adults: The usual dose of clarithromycin is 250 mg (potency) per dose 2 times daily; for severe infections, administer 500 mg (potency) per dose 2 times daily. The usual treatment duration is 7–14 days. In patients with renal failure and creatinine clearance of 30 mL/min or less, the dose should be reduced by half: 250 mg (potency) once daily, or, for severe infections, 250 mg (potency) per dose 2 times daily. Do not administer to these patients for more than 14 days. Mycobacterial infections: Administer 500 mg (potency) per dose 2 times daily. In this case, it should be administered concomitantly with other antimycobacterial agents, such as ethambutol, clofazimine, and rifampin. Eradication of Helicobacter pylori in patients with duodenal ulcers: Administer clarithromycin 500 mg (potency) 3 times daily for 14 days in combination with omeprazole 40 mg once daily, followed by omeprazole 40 mg once daily for 14 consecutive days. That is, administer clarithromycin 500 mg (potency) per dose 3 times daily for 14 days (days 1–14), and omeprazole 40 mg once daily for 28 days (days 1–28). Children 12 years of age and older: same as adults.

Child dose

For children under 12 years of age, use clarithromycin dry syrup.

Precautions

This drug should not be used in patients with allergies to certain ingredients or those who have had hypersensitivity reactions to macrolide antibiotics. Caution should be taken when taking this medication with other drugs that may affect heart rhythm, as it could increase the risk of arrhythmias. In patients with severely impaired liver or kidney function, administration should be avoided or doses adjusted. It is advisable for pregnant or breastfeeding women to avoid taking this drug. This medication can rarely cause severe allergic reactions, skin diseases, liver dysfunction, kidney problems, or central nervous system symptoms, so if any unusual symptoms occur, consult a doctor immediately. It has significant interactions with other drugs; therefore, inform healthcare providers of any medications being taken, and regularly monitor for changes in drug concentration or side effects. Care should be taken as prolonged or high-dose usage may lead to hearing impairment or tinnitus. If gastrointestinal symptoms such as diarrhea or abdominal pain persist, it could signal a serious condition such as pseudomembranous colitis, requiring immediate cessation of use and consultation with healthcare providers. Elderly patients should be administered cautiously, as the drug may remain in the body longer due to reduced bodily functions. During the intake of this medication, dizziness or confusion may occur when driving or operating machinery, so caution is advised.

Side effects

Shock, anaphylactic symptoms, dyspnea, convulsions, flushing, rash, itching, urticaria, skin flushing, angioedema, joint swelling, drug rash, abdominal distension, nausea, vomiting, dyspepsia, abdominal pain, discomfort, flatulence, diarrhea, oral mucosal erosion, epigastric pain, convulsive form, thirst, tooth discoloration, pancreatitis, amylase increase, taste disturbance, loss of appetite, constipation, discoloration of stool, membranous colitis, hemorrhagic colitis, fever, cough, abnormal chest X-ray, eosinophilia, eosinophilic lung infiltration, interstitial pneumonia, chronic bronchitis, acute maxillary sinusitis, eosinophilia, thrombocytopenia, pancytopenia, hemolytic anemia, leukopenia, agranulocytosis, dizziness, depression, loss of taste, loss of smell, anxiety, insomnia, nightmares, tinnitus, confusion, disorientation, hallucinations, psychosis, depersonalization, convulsions, tremors, numbness, behavioral changes, manic behavior, Stevens-Johnson syndrome, toxic epidermal necrolysis, allergic purpura, drug rash with eosinophilia and systemic symptoms, jaundice, hepatocellular hepatitis, cholestatic hepatitis, increased liver enzymes, liver dysfunction, liver failure, fulminant hepatitis, AST elevation, ALT elevation, γ-GTP elevation, LDH elevation, ALP elevation, total bilirubin increase, loss of appetite, dark urine, itching, abdominal tenderness, increased serum creatinine, elevated BUN, interstitial nephritis, renal failure, rhabdomyolysis, myalgia, malaise, elevated CPK, elevated serum myoglobin, elevated urinary myoglobin, glossitis, stomatitis, oral candidiasis, QT prolongation, ventricular tachycardia, Torsades de pointes, fatigue, headache, taste distortion, hearing loss, abnormal sensation, arthralgia, myalgia, olfactory dysfunction, tinnitus, auditory impairment, hypoglycemia, tinnitus, hearing loss, vomiting, nausea, abdominal pain, purpuric rash, acute pancreatitis, increased amylase, AST elevation, ALT elevation, elevated BUN, thrombocytopenia, leukopenia, prolonged prothrombin time, vasodilation, cardiac arrest, atrial fibrillation, ECG QT prolongation, ectopic beats, palpitations, ventricular fibrillation, asthma, epistaxis, pulmonary embolism, esophagitis, gastroesophageal reflux disease, gastritis, rectal pain, belching, bloating, acute pancreatitis, tongue discoloration, tooth discoloration, abnormal liver function tests, bile stasis, hepatitis, alanine aminotransferase elevation, aspartate aminotransferase elevation, gamma-glutamyl transferase elevation, liver failure, rash, diaphoresis, vesicular dermatitis, papular rash, acne, Henoch-Schonlein purpura, acute generalized exanthematous pustulosis, muscle cramps, musculoskeletal rigidity, myopathy, increased serum creatinine, increased urea, renal failure, nephritis, injection site phlebitis, injection site pain, injection site inflammation, fever, weakness, chest pain, chills, fatigue, abnormal albumin-globulin ratio, increased serum alkaline phosphatase, elevated serum lactate dehydrogenase, increased INR, prolonged prothrombin time, abnormal urine color

Not everyone experiences these, and they can vary from person to person.

Storage

This drug may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is best to maintain room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the drug's efficacy and safety for a longer period.

Appearance and packaging

Appearance

Yellow oblong film-coated tablet

Package unit

100 tablets/bottle, 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.